Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX total assets
Total assets on the balance sheet at the end of each period.
Zeo ScientifiX's total assets was $3.89M at Apr 30, 2026. For fiscal 2025 it was $1.53M, down 7.1% from the year before. Over ten years it grew 25.9% a year on average. The highest annual figure on record is $6.20M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.53M | -7.1% |
| FY2024 | Oct 31, 2024 | $1.64M | -40.9% |
| FY2023 | Oct 31, 2023 | $2.78M | -55.1% |
| FY2022 | Oct 31, 2022 | $6.20M | +220.8% |
| FY2021 | Oct 31, 2021 | $1.93M | +44.9% |
| FY2020 | Oct 31, 2020 | $1.33M | +105.6% |
| FY2019 | Oct 31, 2019 | $649.07K | +454.6% |
| FY2018 | Oct 31, 2018 | $117.04K | -68.9% |
| FY2017 | Oct 31, 2017 | $376.78K | +439.0% |
| FY2016 | Oct 31, 2016 | $69.90K | -54.2% |
| FY2015 | Oct 31, 2015 | $152.60K | +1295.2% |
| FY2014 | Oct 31, 2014 | $10.94K | -66.3% |
| FY2013 | Oct 31, 2013 | $32.48K | +75.0% |
| FY2012 | Oct 31, 2012 | $18.56K | -10.6% |
| FY2011 | Oct 31, 2011 | $20.76K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $3.89M | +170.8% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $2.57M | +65.9% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $1.53M | -7.1% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $1.65M | -14.5% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $1.44M | -41.0% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $1.55M | -44.3% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $1.64M | -33.1% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $1.93M | -42.1% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $2.43M | -60.8% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $2.78M | +8.8% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $2.46M | +10.9% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $3.33M | +60.4% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $6.20M | +220.8% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $2.56M | +49.0% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $2.21M | +69.3% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $2.08M | +55.8% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $1.93M | +71.4% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $1.72M | +115.2% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $1.31M | +83.0% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $1.33M | +105.6% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $1.13M | +134.0% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $797.37K | +61.4% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $714.98K | +510.9% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $649.07K | +326.1% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $481.86K | +187.9% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $494.07K | +34.4% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $117.04K | -68.9% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $152.34K | -61.7% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $167.36K | -51.1% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $367.63K | +80.5% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $376.78K | +439.0% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $397.84K | +2856.8% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $342.16K | +552.9% |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $203.66K | +633.9% |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $69.90K | -54.2% |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $13.46K | -90.2% |
| Q2 FY2016CQ1 2016 | Apr 30, 2016 | $52.40K | – |
| Q1 FY2016CQ4 2015 | Jan 31, 2016 | $27.75K | – |
| Q4 FY2015CQ3 2015 | Oct 31, 2015 | $152.60K | – |
| Q3 FY2015CQ2 2015 | Jul 31, 2015 | $136.91K | – |
See a number that looks wrong?